The manufacturer of the product announced Friday that the Food and Drug Administration (FDA) approved the first cervical cancer screening test for cervical cancer.
The DIY test can replace in-person “Pap Smears” and is recommended for women under 65 every three years.
Self-Collection Device - A Tsubasa wand made from San Francisco's Tsubasa Health, allowing women to purchase samples and mail them for laboratory analysis.
The trial results show that new treatments for cervical cancer can reduce the risk of death by 40%.
The test is designed to detect human papillomavirus (HPV), which causes almost all cases of cervical cancer.
The manufacturer of the product announced Friday that the Food and Drug Administration has approved the first cervical cancer screening test for cervical cancer. (iStock)
The approval was conducted after a clinical trial that included more than 600 women, with the turquoise wand detecting neck prec with a precision of 96%.
In this study, 86% of participants said they were more likely to follow cervical cancer screening recommendations if they could do cervical cancer advice at home.
Additionally, 94% said they would like to raise it themselves at home as long as the results are accurate.
Study finds that cervical cancer deaths can be reduced through home HPV tests
“Cervical cancer is basically preventable, but screening rates are still lagging in the U.S., and the FDA’s approval of this family’s cyan self-collection device is a crucial step,” said Christine Conageski, Ph.D., an associate professor at Ob-gyn and associate professor at Complex Dysplasia Clinic, a self-committee, a self-committee.
"It provides an evidence-based way to extend access without compromising accuracy," she added in a statement.
"Cervical cancer is basically preventable, but screening rates in the United States are still lagging behind, and the FDA's approval of this family's cyan self-collection device is an important step forward," said one doctor. (iStock)
According to the Centers for Disease Control and Prevention, about 11,500 new cervical cancer diagnoses are conducted in the United States each year, and the disease causes 4,000 deaths.
Experts say that in addition to the risk of cervical cancer, some of the high-risk incidence of HPV may also cause other types of cancer.
“Any type of test that helps detect cervical cancer is a win.”
Women aged 25 to 65 have an average risk of cervical cancer www.getteal.comAccording to the company's announcement.
The company said in its announcement that the kit is expected to open first in California in June and plans to expand "around the country as soon as possible."
Click here to sign up for our health newsletter
"Teal is working with major insurance providers and plans to have flexible payment options that will help eliminate financial problems and ensure more women get this priority screening in willing home screening," the company said.
About 11,500 new cervical cancer diagnoses are conducted in the United States each year, with 4,000 deaths per year in the disease. (iStock)
In addition to the collection kit, the product also includes telehealth services supported by healthcare providers throughout the process.
Women who test positive for HPV will be referred to a traditional pap smear. Those who did not test positive were not considered risk of cervical cancer and did not require re-screening for three to five years.
Click here to get the Fox News app
“Some women are afraid of traditional pap smears, or find the process uncomfortable—and therefore they postponed this important test,” said the co-host of gynecological oncology at John Cerruel Cancer Center of Hackensack University Medical Center in a press release. (She did not participate in the trial.)
For more health articles, visit www.foxnews.com/health
"This could be an important tool to get more women to screen regularly, especially those who don't have access to health care providers. Any test that helps detect cervical cancer is a win."